Traditionally determined left ventricular hypertrophy was associated with a larger body mass index and systolic and mean blood pressure; the use of a larger number of antihypertensives; more frequent calcium channel blocker, beta blocker and erythropoietin-stimulating agent treatment; and more prevalent established cardiovascular disease. The gene discussed is EPO; the disease is left ventricular hypertrophy.